Mizuho Securities Reiterates Buy on Sucampo Pharma (SCMP) as Amitiza Royalies Drives 2Q Beat

August 3, 2016 9:12 AM

Mizuho Securities reiterated a Buy rating and $14.00 price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) following the company's 2Q earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found